EUVIMEDEUVIMED entdecken
Crossref

Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species

Pranay R Ullengala, Ravindra V Shinde, Satish Patil

Cureus · 21.11.2026

DOI: 10.7759/cureus.120064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 21.11.2026. Verfasst von Pranay R Ullengala und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ullengala, P. R., Shinde, R. V., & Patil, S. (2026). Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species. Cureus. https://doi.org/10.7759/cureus.120064

Vancouver

Ullengala PR, Shinde RV, Patil S. Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species. Cureus. 2026. doi:10.7759/cureus.120064

BibTeX
@article{Ullengala2026,
  author = {Ullengala, Pranay R and Shinde, Ravindra V and Patil, Satish},
  title = {Phenotypic Extended-Spectrum Beta-Lactamase (ESBL) Burden, Multidrug Resistance, and Beta-Lactamase Inhibitor Failure Across Clinical Acinetobacter Species},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.120064}
}
Kostenlos starten →